Transaction DateRecipientSharesTypePriceValue
18th September 2020Global Strategic Fund, L.P. Ven Bio2,829,123Conversion of derivative$0.00
18th September 2020Global Strategic Fund, L.P. Ven Bio230,000Open or private purchase$13.00$2,990,000.00
7th August 2020Llc Fmr356,674Other acquisition or disposition$0.00
15th June 2020Abid Ansari8,783Exercise of derivative$1.20$10,539.60
15th May 2020Abid Ansari8,783Exercise of derivative$1.20$10,539.60
15th May 2020Abid Ansari878Exercise of derivative$1.18$1,036.04
14th April 2020Derek Jantz4,392Exercise of derivative$1.18$5,182.56
10th February 2020Llc Fmr2,189,820Conversion of derivative$0.00
10th February 2020Llc Fmr66,369Conversion of derivative$0.00
10th February 2020Llc Fmr4,715,723Conversion of derivative$0.00
Precision Bio Sciences
Precision Bio Sciences logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.


Precision BioSciences, Inc. engages in the development of genome editing technologies. The company operates through the Therapeutics and Food segments.


Ticker: DTIL
Sector: Health Technology
Industry: Biotechnology
SEC Central Index Key (CIK): 1357874
Employees: 199
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals